Did you mean: Dendroaspis jamesonii ?
Common Names: Jameson's Mamba, Jamesons Mamba, Jameson-Mamba
81. G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors.
Maïga A, Mourier G, Quinton L, Rouget C, Gales C, Denis C, Lluel P, Sénard JM, Palea S, Servent D, Gilles N
Toxicon : official journal of the International Society on Toxinology, 2012
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
82. Natriuretic peptide drug leads from snake venom.
Vink S, Jin AH, Poth KJ, Head GA, Alewood PF
Toxicon : official journal of the International Society on Toxinology, 2012
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
83. Dendroaspis natriuretic peptide is the most potent natriuretic peptide to cause relaxation of lower esophageal sphincter.
Huang SC
Regulatory peptides, 2011
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
84. Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney.
Kim SM, Kim YA, Kim SY, Kim SH, Cho KW, Kim SZ
Regulatory peptides, 2011
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
85. Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the ?2-adrenoceptors.
Rouget C, Quinton L, Maïga A, Gales C, Masuyer G, Malosse C, Chamot-Rooke J, Thai R, Mourier G, De Pauw E, Gilles N, Servent D
British journal of pharmacology, 2010
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
86. Effect of dendroaspis natriuretic peptide (DNP) on L-type calcium channel current and its pathway.
Zhang SY, Cai ZX, Li P, Cai CY, Qu CL, Guo HS
Regulatory peptides, 2010
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
87. CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease.
McKie PM, Sangaralingham SJ, Burnett JC
Current heart failure reports, 2010
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
88. CD-NP, a chimeric natriuretic peptide for the treatment of heart failure.
Rose RA
Current opinion in investigational drugs (London, England : 2000), 2010
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
89. Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor.
Quinton L, Girard E, Maiga A, Rekik M, Lluel P, Masuyer G, Larregola M, Marquer C, Ciolek J, Magnin T, Wagner R, Molgó J, Thai R, Fruchart-Gaillard C, Mourier G, Chamot-Rooke J, Ménez A, Palea S, Servent D, Gilles N
British journal of pharmacology, 2010
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
90. Natriuretic peptides in septic patients.
Piechota M, Barylski M, Hannam S, Mikhailidis DP, Rysz J, Banach M
Current medicinal chemistry, 2009
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0
|
